Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATION - PROLUNG INC | f10q093015_ex31z1.htm |
| EX-32.1 - EXHIBIT 32.1 SECTION 906 CERTIFICATION - PROLUNG INC | f10q093015_ex32z1.htm |
| EX-10.3 - EXHIBIT 10.3 FORM OF CONVERTIBLE NOTE - PROLUNG INC | f10q093015_ex10z3.htm |
| EX-31.2 - EXHIBIT 31.2 SECTION 302 CERTIFICATION - PROLUNG INC | f10q093015_ex31z2.htm |
| 10-Q - FORM 10-Q QUARTERLY REPORT - PROLUNG INC | f10q093015_10q.htm |
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Fresh Medical Laboratories, Inc. (the “Company”) for the three months ended September 30, 2015, as filed with the Securities and Exchange Commission (the “Report”), I, Steven C. Eror, President and Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
|
| |||
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and | |||
|
| |||
2. | The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company. | |||
| ||||
|
|
| ||
Dated: | November 16, 2015 | /s/ Steven C. Eror | ||
|
| Steven C. Eror | ||
|
| Chief Financial Officer (Principal Financial Officer) | ||